Literature DB >> 15528951

Vasopressin stimulates ventromedial hypothalamic neurons via oxytocin receptors in oxytocin gene knockout male and female mice.

André K Ragnauth1, Andrew Goodwillie, Cornelia Brewer, Louis J Muglia, Donald W Pfaff, Lee-Ming Kow.   

Abstract

A wealth of neuropharmacological data demonstrates that oxytocin (OT) actions in the mammalian forebrain support a wide variety of affiliative behaviors and repress aggressive behaviors. Based on that literature, it was expected that reproductive and affiliative behaviors would be vastly decreased and aggression markedly increased in OT gene knockout (OTKO) mice. The initial publications reporting the behaviors of these mice did not include such phenotypes. Here, we compared single-unit activities recorded from the ventromedial hypothalamus in tissue slices of male and female OTKO mice and their wild-type littermate to test two hypotheses about OT functional genomics. First, we proposed that in OTKO mice, a very similar 9-amino-acid neuropeptide, arginine vasopressin (a likely gene duplication product), can 'cross over' and compensate for the lack of OT. This hypothesis was confirmed in both males and females. Further, we proposed that because of the lifelong absence of OT in OTKO, OT receptors would be more sensitive to OT in the knockout animals. We tested this idea in males and found that it was correct. Thus, an answer to the 'OTKO paradox' is put forth, with implications for OT-sensitive behaviors in a variety of species.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528951     DOI: 10.1159/000081844

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  10 in total

Review 1.  Oxytocin and love: Myths, metaphors and mysteries.

Authors:  C Sue Carter
Journal:  Compr Psychoneuroendocrinol       Date:  2021-12-27

2.  A conditional knockout mouse line of the oxytocin receptor.

Authors:  Heon-Jin Lee; Heather K Caldwell; Abbe H Macbeth; Selen G Tolu; W Scott Young
Journal:  Endocrinology       Date:  2008-03-20       Impact factor: 4.736

Review 3.  Comparative Perspectives on Oxytocin and Vasopressin Receptor Research in Rodents and Primates: Translational Implications.

Authors:  Sara M Freeman; Larry J Young
Journal:  J Neuroendocrinol       Date:  2016-04       Impact factor: 3.627

Review 4.  Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery.

Authors:  Zhimin Song; H Elliott Albers
Journal:  Front Neuroendocrinol       Date:  2017-10-18       Impact factor: 8.606

5.  An obligate role of oxytocin neurons in diet induced energy expenditure.

Authors:  Zhaofei Wu; Yuanzhong Xu; Yaming Zhu; Amy K Sutton; Rongjie Zhao; Bradford B Lowell; David P Olson; Qingchun Tong
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

Review 6.  The Oxytocin-Vasopressin Pathway in the Context of Love and Fear.

Authors:  C Sue Carter
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-22       Impact factor: 5.555

7.  Oxytocin and vasopressin flatten dominance hierarchy and enhance behavioral synchrony in part via anterior cingulate cortex.

Authors:  Yaoguang Jiang; Michael L Platt
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

8.  The oxytocin receptor (OXTR) contributes to prosocial fund allocations in the dictator game and the social value orientations task.

Authors:  Salomon Israel; Elad Lerer; Idan Shalev; Florina Uzefovsky; Mathias Riebold; Efrat Laiba; Rachel Bachner-Melman; Anat Maril; Gary Bornstein; Ariel Knafo; Richard P Ebstein
Journal:  PLoS One       Date:  2009-05-20       Impact factor: 3.240

9.  Impairments in the initiation of maternal behavior in oxytocin receptor knockout mice.

Authors:  Megan E Rich; Emily J deCárdenas; Heon-Jin Lee; Heather K Caldwell
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

Review 10.  Is Oxytocin "Nature's Medicine"?

Authors:  C Sue Carter; William M Kenkel; Evan L MacLean; Steven R Wilson; Allison M Perkeybile; Jason R Yee; Craig F Ferris; Hossein P Nazarloo; Stephen W Porges; John M Davis; Jessica J Connelly; Marcy A Kingsbury
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.